A detailed history of Prudential Financial Inc transactions in Precigen, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 20,380 shares of PGEN stock, worth $93,951. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,380
Previous 128,385 84.13%
Holding current value
$93,951
Previous $182,000 63.19%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

SELL
$1.43 - $4.76 $154,447 - $514,103
-108,005 Reduced 84.13%
20,380 $67,000
Q2 2025

Aug 12, 2025

SELL
$1.17 - $1.62 $89,857 - $124,417
-76,801 Reduced 37.43%
128,385 $182,000
Q1 2025

May 13, 2025

BUY
$1.07 - $2.03 $219,549 - $416,527
205,186 New
205,186 $305,000
Q3 2023

Nov 13, 2023

BUY
$1.08 - $1.85 $147,452 - $252,580
136,530 New
136,530 $193,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $960M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.